BABA
Alibaba Group Holding Limited
BABA has the edge over HDL overall, supported by stronger modeled upside.
HDL
SUPER HI INTERNATIONAL HOLDING Ltd. American Depositary Shares
HDL has slightly lower modeled downside risk, despite its lower overall score.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
HDL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Healthy |
HDL's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
HDL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 20x | $5.44 | -49% |
| Fair | 22x | $5.94 | -44% |
| Expensive | 34x | $9.06 | -15% |
| Current | 40x | $10.69 | — |
Historical ranges are pointers, not guarantees.
HDL has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
HDL Forward outlook
There aren't enough analyst estimates for HDL to show an outlook.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over HDL in the latest year-over-year earnings comparison.
HDL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.27 | -70% |
HDL's earnings per share have fallen from their peak: $0.27 over the past year, against $0.90 in mid-2025.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over HDL on profitability, with a higher operating margin.
HDL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $218.7M | +9.9% |
| Q1 2026 | $225.9M | +14% |
| Q4 2025 | $230.3M | +9.6% |
| Q3 2025 | $214M | +7.8% |
| Q2 2025 | $199M | +9.1% |
| Q1 2025 | $197.8M | +4.9% |
| Q4 2024 | $210.1M | +10% |
| Q3 2024 | $198.6M | +15% |
HDL has the edge over BABA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 4.3% | -15 points |
| Q1 2026 | 6.5% | -17 points |
| Q4 2025 | 7.3% | -19 points |
| Q3 2025 | 6% | -21 points |
| Q2 2025 | 20% | -2.1 points |
| Q1 2025 | 24% | -2.6 points |
| Q4 2024 | 26% | +2.7 points |
| Q3 2024 | 27% | +1.9 points |
HDL's operating margin was 4.3% last quarter, down 15 points from the same quarter a year ago, near the bottom of its range since 2021.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
HDL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $28.2M | +6.2% |
| Q1 2026 | $24.2M | +107673% |
| Q4 2025 | $2.7M | -79% |
| Q3 2025 | $34.1M | -16% |
| Q2 2025 | $26.6M | +11% |
| Q1 2025 | $22.5K | -100% |
| Q4 2024 | $12.8M | -27% |
| Q3 2024 | $40.7M | +133% |
HDL has the edge over BABA on cash generation, producing positive trailing cash flow while its opponent burns cash.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has the edge over HDL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
HDL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +44% | +17.9M shares |
| 1 year | +7.5% | +4.1M shares |
HDL has 59M diluted shares, up 7.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
HDL hasn't bought back shares in the past year.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA has the edge over HDL on leverage, with a lower net debt burden relative to earnings.
HDL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 1.0x | Very low |
| Q4 2025 | -0.4x | Net Cash |
| Q3 2025 | 0.0x | Very low |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.4x | Net Cash |
| Q3 2024 | -0.2x | Net Cash |
HDL's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
HDL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.9 | Neutral |
| Stochastic | 9.0 | Oversold |
HDL's weekly RSI is 38 (neutral) and its Stochastic is 9 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA has the edge over HDL on valuation relative to its sector.
HDL PE vs Consumer Cyclical Sector
| Metric | HDL | Sector median | Relative |
|---|---|---|---|
| PE | 40x | 18x | 121% above |
| PE % | 100 | 23 | 77 pts above |
HDL is trading at 40x earnings, a 121% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
HDL has stronger trend alignment. BABA is above 0 of 5 weekly averages versus HDL above 0 of 4.
HDL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.8 | 0.6% below |
| 20 week MA | $12.0 | 11% below |
| 50 week MA | $14.0 | 24% below |
| 100 week MA | $17.6 | 39% below |
HDL is in a downtrend: it's below all four of its weekly moving averages, and 39% below its 100-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
HDL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $22.3 | $27.3 | +22% |
| 2025 | $27.3 | $16.3 | -40% |
| 2026 YTD | $16.3 | $10.7 | -34% |
HDL has the edge over BABA on returns for 2026, with the stronger performance.